Skip to main content

Table 3 Bivariate analysis for invasive mechanical ventilation

From: Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia

Variable

Overall

(n = 5161)

No requirement of invasive mechanical ventilation (n = 4263)

Missing (n)

Invasive mechanical ventilation (n = 898)

Missing (n)

p-value

Demographic

 Age median (IQR)

66 (53–77)

65 (51–78)

0

68 (59–75)

0

< 0.01*

 Days of ICU (IQR)

 

4 (2–7)

3891

11 (7–18)

60

< 0.01*

 Days of hospital stay (IQR)

8 (4–13)

7 (3–11)

0

16 (10–25)

0

< 0.01*

 Body mass index median (IQ)

26.34 (23.4–29.38)

26.1 (23.4–29.2)

3

27.3 (24.3–31.1)

0

< 0.01*

Sex

 Female

2340 (45.34%)

2036 (87%)

-

304 (12%)

-

< 0.01*

 Male

2821 (54.65%)

2227 (78%)

-

594 (21%)

-

< 0.01*

Management site

 Outpatient

854 (16.54%)

854 (100%)

-

0 (0%)

-

-

 Inpatient

2970 (57.54%)

2962 (99%)

-

8 (0.002%)

-

-

 Emergency

114 (2.20%)

75 (65%)

-

39 (34%)

-

-

 ICU

1223 (23.69%)

372 (30%)

-

851 (70%)

-

-

Outcome

 Alive

3856 (75%)

3571 (92%)

-

285 (0.7%)

-

< 0.01*

 Dead

1305 (25%)

692 (53%)

-

613 (46%)

-

< 0.01*

Comorbidities

 Hypertension

1171 (22.68%)

935 (79%)

-

236 (20%)

-

< 0.01*

 HIV

9 (0.17%)

8 (88%)

-

1 (11%)

-

-

 COPD

290 (5.61%)

232 (8%)

-

58 (2%)

-

-

 Diabetes mellitus

256 (4.96%)

193 (0.37%)

-

63 (0.12%)

-

< 0.01*

Laboratory values (IQR)

 Leukocyte blood count

7,985 (0.2–262.9)

7.7 (5.72–10.49)

432

9.27 (6.7–12.95)

7

< 0.01*

 Neutrophil-lymphocyte ratio

6,0303 (3,4258–10,7008)

5,436 (3,168–9,674)

434

9,378 (5,399–16,548)

8

< 0.01*

 Haematocrit

43.4 (39.2–47)

43.3 (39.2–46.9)

427

43.9 (39.4–47.5)

7

< 0.01*

 Haemoglobin

14.5 (13–15.8)

14.4 (13–15.7)

426

14.7 (13.1–16)

7

< 0.01*

 LDH

337 (255–445)

317 (243–407)

725

453.5 (341–590)

40

< 0.01*

 D-Dimer

950 (540–1802.25)

920 (523.2–1711.5)

937

1093 (600–2028)

76

< 0.01*

 Procalcitonin

0.31 (0.12–1.01)

0.2 (0.09–0.58)

3347

0.58 (0.23–1.92)

245

< 0.01*

 Ferritin

881 (478–1612.5)

816 (462–1538)

4002

1244 (79.7–1925.7)

832

< 0.01*

Oxygenation indices (IQR)

 S/F ratio at admission

339.28 (310.71–423.80)

342,857 (321.4–428.57)

163

300 (161–347)

3

< 0.01*

 S/F ratio at 48 h

325 (254.28–341.52)

328.57 (307.1–346.4)

777

202.2(145–317)

29

< 0.01*

 P/F ratio at admission

233,3854 (180,9524–274,6429)

243.21 (200.4–281)

777

171.4 (98.2–231.4)

29

< 0.01*

 S/F ratio at ICU admission

 

278.1 (156.6–332.1)

3942

150 (96–192)

69

< 0.01*

 P/F ratio at ICU admission

 

154.5 (91–244.9)

3973

112.6 (79.9–150.5)

76

< 0.01*

  1. ICU intensive care unit, COPD chronic obstructive pulmonary disease, HIV human immunodeficiency virus, LDH lactate dehydrogenase, S/F oxygen saturation to fraction inspired oxygen, P/F partial pressure of oxygen to fraction inspired oxygen
  2. *P-value refers to statistically significant result